| Unbound MEDLINE results for: | Bookmark this site | | Articles related to 18827726 [Unique ID], provided by the PubMed system | |
| |
|
| | 1 - 10 of 95 journal articles in the PubMed database | Email to a friend | | |
| Vogelbaum MA, Sampson JH, Kunwar S, et al.
CONVECTION-ENHANCED DELIVERY OF CINTREDEKIN BESUDOTOX (INTERLEUKIN-13-PE38QQR) FOLLOWED BY RADIATION THERAPY WITH AND WITHOUT TEMOZOLOMIDE IN NEWLY DIAGNOSED MALIGNANT GLIOMAS: PHASE 1 STUDY OF FINAL SAFETY RESULTS. [JOURNAL ARTICLE]
Neurosurgery 2008 Sep 15.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Vogelbaum MA, Sampson JH, Kunwar S, et al.
Convection-enhanced delivery of cintredekin besudotox (interleukin-13-PE38QQR) followed by radiation therapy with and without temozolomide in newly diagnosed malignant gliomas: phase 1 study of final safety results. [Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't]
Neurosurgery 2007 Nov; 61(5):1031-7; discussioin 1037-8.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Kunwar S, Prados MD, Chang SM, et al.
Direct intracerebral delivery of cintredekin besudotox (IL13-PE38QQR) in recurrent malignant glioma: a report by the Cintredekin Besudotox Intraparenchymal Study Group. [Clinical Trial, Phase I, Journal Article]
J Clin Oncol 2007 Mar 1; 25(7):837-44.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Kunwar S, Chang SM, Prados MD, et al.
Safety of intraparenchymal convection-enhanced delivery of cintredekin besudotox in early-phase studies. [Journal Article]
Neurosurg Focus 2006; 20(4):E15.
Abstract | Full Citation | Find Related Articles | | Lanzetta G, Campanella C, Rozzi A, et al.
Temozolomide in radio-chemotherapy combined treatment for newly-diagnosed glioblastoma multiforme: phase II clinical trial. [Clinical Trial, Clinical Trial, Phase II, Journal Article]
Anticancer Res 2003 Nov-Dec; 23(6D):5159-64.
Abstract | Full Citation | Find Related Articles | | Langer CJ, Ruffer J, Rhodes H, et al.
Phase II radiation therapy oncology group trial of weekly paclitaxel and conventional external beam radiation therapy for supratentorial glioblastoma multiforme. [Clinical Trial, Clinical Trial, Phase II, Journal Article, Multicenter Study]
Int J Radiat Oncol Biol Phys 2001 Sep 1; 51(1):113-9.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Stupp R, Dietrich PY, Ostermann Kraljevic S, et al.
Promising survival for patients with newly diagnosed glioblastoma multiforme treated with concomitant radiation plus temozolomide followed by adjuvant temozolomide. [Clinical Trial, Clinical Trial, Phase II, Journal Article]
J Clin Oncol 2002 Mar 1; 20(5):1375-82.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Korones DN, Benita-Weiss M, Coyle TE, et al.
Phase I study of temozolomide and escalating doses of oral etoposide for adults with recurrent malignant glioma. [Clinical Trial, Clinical Trial, Phase I, Journal Article]
Cancer 2003 Apr 15; 97(8):1963-8.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Brock CS, Newlands ES, Wedge SR, et al.
Phase I trial of temozolomide using an extended continuous oral schedule. [Clinical Trial, Clinical Trial, Phase I, Journal Article, Multicenter Study]
Cancer Res 1998 Oct 1; 58(19):4363-7.
Abstract | Full Citation | Find Related Articles |   |
|
| |
Advertise on this site.
|
